Tag: MESI mTABLET ABI

The MESI mTABLET ABI has been chosen as a finalist in the Cardiovascular Devices category in the 2021 Medical Design Excellence Awards competition

Coronary/Structural Heart by 0 comments

LJUBLJANA, Slovenia, April 29, 2021 /PRNewswire/ — MESI mTABLET ABI, device used for early detection of Peripheral Arterial Disease (PAD) by measuring Ankle-Brachial Index (ABI), has been announced as a finalist in the Cardiovascular Device category in the 2021 Medical Design Awards (MDEA) competition. MDEA is the premier awards program for the MedTech […]

Continue Reading →

New technology advancement by MESI in detecting Peripheral-Arterial Disease to benefit US patients

Peripheral/Endo by 0 comments

LJUBLJANA, Slovenia, March 23, 2021 /PRNewswire/ — MESI mTABLET ABI, device used for early detection of Peripheral Arterial Disease (PAD) by measuring Ankle-Brachial Index (ABI), was cleared for marketing and sales by the Food and Drug Administration in December 2020. MESI mTABLET ABI is a unique healthcare solution, integrating wireless diagnostic modules for Ankle-Brachial […]

Continue Reading →